By Gregory Hesse and Kaleb Bailey ( August 5, 2024, 1:58 PM EDT) -- In its April In re: Mallinckrodt PLC decision, the U.S. Court of Appeals for the Third Circuit held that Mallinckrodt could discharge its obligation to pay future royalties to Sanofi-Aventis US LLC, a drug developer that sold "the rights to the drug outright" to Mallinckrodt for $100,000 up front and a promise to pay a one percent royalty on all net sales over $10 million a year in perpetuity.[1]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.